financetom
Business
financetom
/
Business
/
Phillips 66 to buy remaining WRB Refining stake from Cenovus for $1.4 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Phillips 66 to buy remaining WRB Refining stake from Cenovus for $1.4 billion
Sep 9, 2025 4:37 AM

Sept 9 (Reuters) - Phillips 66 said on Tuesday

it will acquire the remaining 50% stake in WRB Refining from

units of Cenovus Energy ( CVE ) for $1.4 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biodexa Pharmaceuticals Files Europe Clinical Trial Application for Potential Familial Adenomatous Polyposis Treatment
Biodexa Pharmaceuticals Files Europe Clinical Trial Application for Potential Familial Adenomatous Polyposis Treatment
Jul 14, 2025
08:56 AM EDT, 07/14/2025 (MT Newswires) -- Biodexa Pharmaceuticals ( BDRX ) said Monday it has filed a clinical trial application with the European Medicines Agency for trial of Serenta in patients with familial adenomatous polyposis. Familial adenomatous polyposis is a genetic disease that if untreated often leads to colorectal cancer. The application is required to obtain approval to begin...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives
Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives
Jul 14, 2025
08:56 AM EDT, 07/14/2025 (MT Newswires) -- Journey Medical ( DERM ) said Monday that 65% of the 187 million commercial lives in the U.S. now have pharmacy benefit coverage for Emrosi, its recently launched treatment for inflammatory lesions of rosacea in adults. The company said it marks an increase from 29% coverage in May. ...
Sector Update: Consumer
Sector Update: Consumer
Jul 14, 2025
08:57 AM EDT, 07/14/2025 (MT Newswires) -- Consumer stocks were leaning lower pre-bell Monday as the Consumer Staples Select Sector SPDR Fund (XLP) was down 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was marginally declining recently. Kenvue ( KVUE ) said its board has appointed director Kirk Perry as interim chief executive officer, starting immediately. Shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved